Kaoru Kobayashi

Kiyose, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 174 publications

Evaluation of drug-drug interactions of traditional Japanese medicines (Hochuekkito, Goreisan, and Ninjin'yoeito) in CYP3A-humanised mice.

Evaluation of drug-drug interactions of traditional Japanese medicines (Hochuekkito, Goreisan, and Ninjin'yoeito) in CYP3A-humanised mice.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: June 10, 2026

Development of a Quantitative Detection System for Porphyromonas gingivalis Based on Immunochromatography.

Development of a Quantitative Detection System for Porphyromonas gingivalis Based on Immunochromatography.

Journal: Dentistry journal

Published: April 03, 2026

CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene.

CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: February 06, 2026

Characterization of fatty acid amide hydrolase 2 as a drug-metabolizing enzyme: Contribution to the hydrolysis of DS-8500a and its analogs.

Characterization of fatty acid amide hydrolase 2 as a drug-metabolizing enzyme: Contribution to the hydrolysis of DS-8500a and its analogs.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: September 30, 2025

Measuring the Invisible: Microbial Diagnostics for Periodontitis-A Narrative Review.

Measuring the Invisible: Microbial Diagnostics for Periodontitis-A Narrative Review.

Journal: International journal of molecular sciences

Published: August 29, 2025

Double-humanized Rats for CYP3A and PXR as an Improved Model for Analyzing Drug-drug Interactions Mediated by CYP3A4.

Double-humanized Rats for CYP3A and PXR as an Improved Model for Analyzing Drug-drug Interactions Mediated by CYP3A4.

Journal: The AAPS journal

Published: April 23, 2025

Contribution of Japanese scientists to drug metabolism and disposition.

Contribution of Japanese scientists to drug metabolism and disposition.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: December 29, 2024

Subjectively Low Oral Function Is Associated With Physical Frailty and Polypharmacy in Community-Dwelling Older Adults.

Subjectively Low Oral Function Is Associated With Physical Frailty and Polypharmacy in Community-Dwelling Older Adults.

Journal: Gerodontology

Published: July 15, 2024

Evaluation of a Novel Immunochromatographic Device for Detecting Porphyromonas gingivalis in Patients with Periodontal Disease.

Evaluation of a Novel Immunochromatographic Device for Detecting Porphyromonas gingivalis in Patients with Periodontal Disease.

Journal: International journal of molecular sciences

Published: June 25, 2024

Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial.

Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial.

Journal: Regenerative therapy

Published: March 20, 2024

High-throughput assay to simultaneously evaluate activation of CYP3A and the direct and time-dependent inhibition of CYP3A, CYP2C9, and CYP2D6 using liquid chromatography-tandem mass spectrometry.

High-throughput assay to simultaneously evaluate activation of CYP3A and the direct and time-dependent inhibition of CYP3A, CYP2C9, and CYP2D6 using liquid chromatography-tandem mass spectrometry.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: January 24, 2024

Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics.

Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics.

Journal: Pharmacology research & perspectives

Published: January 18, 2024

Showing 1-12 of 174

Last Updated: 09/26/2026